This session will review trends in substance use and overdose in Philadelphia, PA, and the United States. Treatment recommendations including harm reduction resources and benefits…
Buprenorphine is one of the gold standard medications utilized for treatment of opioid use disorder (OUD). One of the major barriers to buprenorphine maintenance is…
This session will explore evidence demonstrating how addiction can be considered a pediatric disease as well as treatment currently provided to adolescent patients with Opioid…
This session will explore the many ways in which opioid epidemic affects pediatric medicine, from toddler exploratory poisonings, to young patients’ parental loss, neonatal abstinence…
The ongoing opioid epidemic in the United States has translated into a public health emergency due to the rising cases of Neonatal Abstinence Syndrome (NAS)…
Neonatal abstinence syndrome (NAS) and neonatal opioid withdrawal syndrome (NOWS) have skyrocketed as a result of the ongoing opioid epidemic. Celina C.S. Migone, MD, attending…
Notice: This lecture was delivered in 2017 in Salzburg, Austria. Due to scheduling changes in the OMI-CHOP curriculum, this content is next due to be…
Notice: This lecture was delivered in 2017 in Salzburg, Austria. Due to scheduling changes in the OMI-CHOP curriculum, this content is next due to be…
Drs. Diane Calello and Kevin Osterhoudt “Talk Tox” with host Dr. Bob Belfer. Topics include: use of the TOX screen, epidemiology and treatment of tylenol,…
In celebration of the 100th episode of the Primary Care Perspectives podcast, Dr. Katie Lockwood welcomes a special guest, author Jessica Lahey, to discuss her…
**By selecting “Yes”, you consent to receive information from CHOP. Once you have decided to receive such communications, you may later decide to stop receiving these communications. If you want to stop receiving these communications, you may send an email message to chopopensupport@chop.edu.